Skip to main content

Basic, translational and clinical research

Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Click the link to read more about the journal.

Special article collections

Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far by clicking the link above. 

We welcome further submissions to these collections. 

Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!


  1. Authors: Camila Sales Nascimento, Naiara Clemente Tavares, Izabella Cristina Andrade Batista, Mônica Maria Magalhães Caetano, Eneida Santos de Oliveira, Stella Garcia Colombarolli, Anna Carolina Pinheiro Lage, Rodrigo Corrêa-Oliveira, Érica Alessandra Rocha Alves, Celso Pinto de Melo and Carlos Eduardo Calzavara-Silva

Stay up to date

Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Journal Metrics

  • 2022 Citation Impact
    5.7 - 2-year Impact Factor
    6.9 - 5-year Impact Factor
    1.045 - SNIP (Source Normalized Impact per Paper)
    0.882 - SJR (SCImago Journal Rank)

    2022 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    126 days submission to accept (Median)

    2022 Usage 
    242 Altmetric mentions